A clear 2026 breakdown of which cannabinoids remain legal under Germany's NpSG, which semi-synthetic compounds many EU-facing retailers restrict in line with it, and why legal status can still vary by country.
As of 2026, the cannabinoids still legal under Germany's NpSG framework are CBD, CBDA, CBG, CBGA, CBN, CBC, CBDV, CBL, and naturally occurring THCV. These are unregulated because they occur naturally in hemp and are not classified as controlled or novel psychoactive substances. Semi-synthetic cannabinoids — HHC, HHC-P, HHC-O, THCP, THCH, THCB, THCjd, and concentrated Delta-8 or Delta-10 THC — are banned or heavily restricted under Germany's NpSG, having been added to its controlled-substances schedule in a series of amendments starting in 2024 and continuing through subsequent updates. Delta-9 THC itself remains separately controlled under German narcotics law rather than the NpSG. Hemp and THC content limits are also subject to national and EU-level thresholds that vary from one country to the next, so it's worth checking the applicable local limits before buying or traveling with any product.
That's the short answer. The longer answer — why this list looks the way it does, how it keeps shifting, and what it actually means for anyone shopping for legal THC alternatives — is what the rest of this guide breaks down.
What the NpSG actually regulates
The Neue-psychoaktive-Stoffe-Gesetz (NpSG), Germany's "New Psychoactive Substances Act," was originally written to catch synthetic drugs that didn't fit neatly into existing narcotics law — things cooked up in a lab and sold before regulators even had a name for them. It works by listing entire chemical substance groups rather than single named compounds, which is exactly why it became the tool German authorities reached for when semi-synthetic cannabinoids like HHC started appearing on shelves.
Because Germany is one of the largest and most tightly scrutinized cannabinoid markets in the EU, its NpSG rulings have become a de facto reference point for retailers and manufacturers elsewhere in the bloc. When a compound gets added to the German schedule, many EU-facing brands remove it from EU listings or adjust sourcing and sales across multiple markets, since compliant sourcing and lab testing are often built around the strictest applicable standard — but practices vary by retailer and country, and this remains a German legal framework rather than an EU-wide rule.
The 2026 update to this list is not a one-off event — it's the latest step in a pattern that started with the first HHC-related amendments and has continued as chemists develop new semi-synthetic analogues faster than lawmakers can name them individually. Understanding that pattern is more useful than memorizing any single year's list, because the list itself will keep moving.
Naturally occurring, non-intoxicating-framed cannabinoids from hemp remain outside the NpSG's scope. Lab-modified or semi-synthetic THC analogues are the ones consistently getting added to the banned schedule.
Legal cannabinoids in 2026: the full list
The table below lists cannabinoids that remain unregulated under Germany's NpSG. This reflects Germany's NpSG specifically; many EU-facing retailers align their sourcing and catalogs to this German framework, but legal status and availability can still vary by country — always check applicable local laws and regulations before buying.
| Cannabinoid | Legal status (2026) | Why it remains unregulated |
|---|---|---|
| CBD (Cannabidiol) | Legal | Naturally occurring, non-intoxicating framing; not listed under the NpSG or narcotics schedules |
| CBDA (Cannabidiolic acid) | Legal | Raw precursor to CBD, naturally occurring in unheated hemp |
| CBG (Cannabigerol) | Legal | Naturally occurring minor cannabinoid, not structurally close to THC |
| CBGA (Cannabigerolic acid) | Legal | Precursor cannabinoid, unmodified from its natural plant state |
| CBN (Cannabinol) | Legal | Forms naturally as THC degrades with age and light exposure |
| CBC (Cannabichromene) | Legal | Naturally occurring, minor presence in most hemp cultivars |
| CBDV (Cannabidivarin) | Legal | Naturally occurring propyl variant of CBD |
| CBL (Cannabicyclol) | Legal | Naturally occurring, non-psychoactive-framed byproduct compound |
| THCV (Tetrahydrocannabivarin) | Legal in naturally occurring hemp-derived form | Occurs naturally at low concentrations; not classified as a novel psychoactive substance |
For readers who want to understand how CBD's legal, non-intoxicating status actually differs from THC's controlled status at a molecular and effects level, our CBD vs THC effects guide covers that comparison in more depth.
Cannabinoids banned or restricted under the NpSG
The cannabinoids below have been added to Germany's controlled-substances schedule via NpSG amendments, starting with the initial wave targeting HHC in 2024 and expanding to cover its close chemical relatives in the amendments that followed. This reflects Germany's NpSG specifically, and many EU-facing retailers adapt their sourcing to match it — treat this as the negative list to cross-check any product against before buying, and always confirm applicable local rules where you are.
- HHC (Hexahydrocannabinol) — the first semi-synthetic cannabinoid explicitly added to the German schedule; production involves hydrogenating CBD, which regulators classified as chemical modification rather than natural occurrence.
- HHC-P and HHC-O — structural derivatives of HHC, added under the same regulatory logic once they appeared as replacement products.
- THCP (Tetrahydrocannabiphorol) — a THC analogue with a longer side chain, restricted for its close structural relationship to Delta-9 THC.
- THCH (Tetrahydrocannabihexol) and THCB (Tetrahydrocannabutol) — semi-synthetic THC homologues restricted alongside THCP.
- THCjd — a longer-chain THC analogue that followed the same restriction pattern as it entered the market.
- Delta-8 THC and Delta-10 THC (concentrated/synthesized forms) — while trace natural amounts exist in hemp, commercially sold concentrations are produced through chemical conversion and are treated as controlled under the NpSG.
Enforcement and product availability still vary by country even where a compound is restricted under Germany's NpSG. For a look at how one specific market handles this in practice, see our breakdown of cannabinoid restrictions in Croatia.
The pattern behind the bans: why some cannabinoids survive and others don't
Once you line up the legal list against the banned list, a pattern emerges. Regulators are not reacting to cannabinoids in general — they're reacting to three specific factors.
- Structural closeness to THC. Compounds like THCP and THCB are chemically similar enough to Delta-9 THC that they're treated as functional equivalents, regardless of naming.
- Ease of semi-synthetic production. HHC and its derivatives can be produced cheaply by chemically converting CBD, which made them scale quickly on the market — and made them an obvious first target for the NpSG.
- Psychoactivity framing. Cannabinoids designed or converted specifically to produce effects akin to THC attract regulatory attention faster than those that don't.
Cannabinoids that occur naturally in the plant, at naturally occurring concentrations, and aren't chemically converted in a lab tend to stay off the schedule — which is exactly why CBD, CBG, and CBN remain untouched while their lab-modified cousins keep getting added to the list. For a deeper look at how cannabinoid molecular structure maps onto how closely a product's effects mirror THC, see our comparison of full spectrum vs broad spectrum buds.
This pattern is our reading of the regulatory trend, not a guarantee of how future amendments will be worded — new analogues can still appear and get evaluated on their own terms.
What the 2026 update changes for shoppers
For most shoppers, the practical effect of the 2026 update is narrower than the headline suggests. The cannabinoids most people already buy — CBD flower, CBG products, CBN-based items — are unaffected. What has changed is the disappearance of an entire tier of semi-synthetic THC-mimicking products (HHC vapes, THCP concentrates, and similar) that were sold as a bridge between CBD and THC, at least among retailers who align their sourcing to Germany's NpSG.
Retailers who source compliantly with the NpSG have already adjusted their catalogs around this, which is why product availability increasingly maps directly onto the legal-vs-banned split described above rather than onto marketing categories. If a listing still describes itself using one of the banned compound names, that's a signal the retailer hasn't updated its sourcing — worth treating as a red flag rather than a bargain. Legal status and enforcement can still differ by country, so always check applicable local laws and regulations before buying.
To see what a fully updated, compliant catalog actually looks like against this list, browse the hub of compliant legal THC alternative products.
Legal THC alternatives still available in 2026
With the semi-synthetic tier off the table among NpSG-aligned retailers, the compliant market has consolidated around a smaller number of well-defined categories, framed strictly around their psychoactive-effect profiles rather than any specific outcome:
- CBD flower and concentrates — non-intoxicating framing, positioned around relaxation and sensory enjoyment.
- CBG and CBN-led products — minor cannabinoid profiles used for variety in effect and flavor without crossing into controlled territory.
- Full spectrum and broad spectrum hemp buds — blends of naturally occurring cannabinoids formulated to sit closer to or further from a THC-like sensory profile depending on the blend.
- Vaporizer devices and accessories — hardware itself isn't a controlled substance, but what you load into it is, so device choice matters less than the cannabinoid inside the cartridge.
Products in this category are designed to provide psychoactive effects akin to THC — think relaxation, sensory enhancement, or a lifted mood — through legal, naturally occurring cannabinoids rather than semi-synthetic conversions. You can shop the current range of legal THC alternative products directly. For how these categories play out at the country level, our guide to legal vapes in Italy covers a market with its own recent regulatory shifts.
How to verify a product's legal status before buying
Regulatory lists move faster than most product pages get updated, so it's worth checking a few things yourself before adding anything to your cart:
- Look for a Certificate of Analysis (COA). A legitimate compliant product should have batch-specific lab testing available, showing exactly which cannabinoids are present and at what concentration.
- Check the ingredient list against the banned list above. If a product name or description includes HHC, THCP, THCH, THCB, HHC-P, HHC-O, or THCjd, treat it as non-compliant with Germany's NpSG regardless of how it's marketed.
- Confirm batch-level testing, not just a generic product sheet. Cannabinoid concentrations can vary between production runs; a one-time lab report from years ago isn't sufficient verification.
- Read the retailer's compliance statement. A retailer that clearly states its products comply with applicable laws and regulations in the EU — and can back that up with documentation — is a stronger signal than marketing copy alone.
- Confirm applicable local rules for your own country. Even where a retailer sources in line with Germany's NpSG, legal status and enforcement can still vary from one EU country to another.
- Be skeptical of vague marketing that promises unspecified or intense psychoactive effects. Compliant sellers describe effects in terms of relaxation, sensory profile, or mood — not promises of intensity or intoxication.
Frequently asked questions about legal cannabinoids in 2026
Is HHC still legal in 2026?
Under Germany's NpSG, no. HHC was added to the schedule in 2024 and remains restricted going into 2026, along with its derivatives HHC-P and HHC-O. Many EU-facing retailers align their sourcing to this German framework, but always check applicable local laws where you are.
Is CBD affected by the NpSG?
No. CBD is a naturally occurring, non-intoxicating-framed cannabinoid and has never fallen under the NpSG's scope, which targets novel and semi-synthetic psychoactive substances.
Does the NpSG list apply across the whole EU?
The NpSG is German law, but because Germany is a major reference market, many EU-facing retailers align their sourcing to it. Individual EU countries can still have their own additional rules, so always check applicable local regulations — see our country-specific guide on legal vapes in Austria for an example of how this plays out elsewhere.
Are THCP, THCH, and THCB legal under Germany's NpSG?
No — these semi-synthetic THC analogues are restricted under the same regulatory logic that covers HHC, and retailers that align their sourcing to Germany's NpSG typically don't stock them. Legal status and availability can differ elsewhere in the EU, so check applicable local rules before assuming otherwise.
What should I buy instead of banned semi-synthetic cannabinoids?
CBD, CBG, CBN, and full or broad spectrum hemp products remain the compliant options under Germany's NpSG, formulated to provide psychoactive effects akin to THC through naturally occurring cannabinoids rather than lab-converted ones.
